New Delhi. After the demise of the Big Bull of the stock market Rakesh Jhunjhunwala, his portfolio is now being managed by his wife Rekha Jhunjhunwala. The recent market decline has also affected Rekha Jhunjhunwala's portfolio. While the Sensex and Nifty have declined by 8-9% after the September quarter, the value of Rekha Jhunjhunwala's portfolio has decreased by about 13%. According to data till November 21, the total value of Rekha Jhunjhunwala's portfolio has come down to Rs 48,165.59 crore.

At the end of the September quarter, the total value of Rekha Jhunjhunwala's portfolio was Rs 55,095.88 crore. Thus, a decline of about Rs 6,930.29 crore has been registered. The five major stocks of the Jhunjhunwala family - Titan, Conrad Biotech, Star Health and Allied Insurance, Tata Motors, and Metro Brands have not given any positive returns since the September quarter. These stocks have declined by 6% to 24%.

Titan Company Limited fell 15%
Jhunjhunwala has a 5.1% stake in Titan Company. Since September 30, this stock has fallen by 15.80%. The main reason for this decline is believed to be the company's weak second-quarter (Q2) results. Brokerage companies like Goldman Sachs and Jefferies believe that the reduction in customs duty boosted the sale of jewelry, but this has led to a decline in margins.

Tata Motors
The Jhunjhunwala family holds a 1.3% stake in Tata Motors. The stock has fallen by about 20% since September 30. Incred Equities said that despite a better product mix, weak average selling price (ASP), declining gross margins, and rising marketing expenses are a matter of concern.

Star Health and Allied Insurance
Star Health shares have fallen by 24%. Its September quarter results saw a 4.10 percent increase in the claim ratio. Analysts believe that the expense ratio may decrease as the company's scale increases. However, this will depend on the pricing and product mix of its products. Motilal Oswal has recommended buying it with a target of Rs 630.